mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |